M. Nauck Et Al. , "Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: A randomized, double-blind, non-inferiority trial," DIABETES, OBESITY AND METABOLISM , vol.9, no.2, pp.194-205, 2007
Nauck, M. Et Al. 2007. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: A randomized, double-blind, non-inferiority trial. DIABETES, OBESITY AND METABOLISM , vol.9, no.2 , 194-205.
Nauck, M., Meininger, G., Sheng, D., Terranella, L., Stein, P., 024 Group, S. S., ... Satman, İ.(2007). Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: A randomized, double-blind, non-inferiority trial. DIABETES, OBESITY AND METABOLISM , vol.9, no.2, 194-205.
Nauck, M.A. Et Al. "Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: A randomized, double-blind, non-inferiority trial," DIABETES, OBESITY AND METABOLISM , vol.9, no.2, 194-205, 2007
Nauck, M.A. Et Al. "Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: A randomized, double-blind, non-inferiority trial." DIABETES, OBESITY AND METABOLISM , vol.9, no.2, pp.194-205, 2007
Nauck, M. Et Al. (2007) . "Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: A randomized, double-blind, non-inferiority trial." DIABETES, OBESITY AND METABOLISM , vol.9, no.2, pp.194-205.
@article{article, author={M.A. Nauck Et Al. }, title={Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: A randomized, double-blind, non-inferiority trial}, journal={DIABETES, OBESITY AND METABOLISM}, year=2007, pages={194-205} }